• Title/Summary/Keyword: Pharmaceutical preparation

Search Result 652, Processing Time 0.024 seconds

Hsa_Circ_0001947/MiR-661/DOK7 Axis Restrains Non-Small Cell Lung Cancer Development

  • Bao, Yuyan;Yu, Yanjie;Hong, Bing;Lin, Zhenjian;Qi, Guoli;Zhou, Jie;Liu, Kaiping;Zhang, Xiaomin
    • Journal of Microbiology and Biotechnology
    • /
    • v.31 no.11
    • /
    • pp.1508-1518
    • /
    • 2021
  • Hsa_circ_0001947 is associated with multiple cancers, but its function in non-small cell lung cancer (NSCLC) is ambiguous and needs further research. The targeting relationship among circ_0001947, miR-661, and downstream of tyrosine kinase 7 (DOK7) was predicted by database and further verified by dual-luciferase reporter assay, while their expressions in cancer tissues and cells were detected by quantitative real-time polymerase chain reaction (qRT-PCR). After transfection, cell biological behaviors and expressions of miRNAs, miR-661 and DOK7 were determined by cell function experiments and qRT-PCR, respectively. Circ_0001947 was low-expressed in NSCLC tissues and cells. Circ_0001947 knockdown intensified cell viability and proliferation, induced cell cycle arrest at S phase, suppressed apoptosis and evidently enhanced miR-510, miR-587, miR-661 and miR-942 levels, while circ_0001947 overexpression did the opposite. MiR-661 was a target gene of circ_0001947 that participated in the regulation of circ_0001947 on cell biological behaviors. Furthermore, DOK7, the target gene of miR-661, partly participated in the regulation of miR-661 on cell viability. Hsa_circ_0001947 acts as a sponge of miR-661 to repress NSCLC development by elevating the expression of DOK7.

Effects of Some Factors on the Preparation of Spherical Particles by Extrusion-spheronization Processing. I (압출-구형화 공정에 의한 구형과립제조의 제형향인자 검토 (제1보))

  • 이강춘;민신홍;이상의;김용배;이철우
    • YAKHAK HOEJI
    • /
    • v.18 no.4
    • /
    • pp.236-242
    • /
    • 1974
  • Extrusion-spheronization processing combination was used to produce spherical granules with experimental formulations which contain microcrystalline cellulose as a diluent. The produced granules were compared on the basis of the following physical properties ; (a) bulk density, (e) porosity, (f) friabillity and (g) dissolution rate. With the specific experimental formulations used in this study, the increased plate rotational speeds of Marumerizer (400-1200rpm) produced continually more spherical material and also the obtained data indicated that the particle size distribution and dissolution rate depend upon the amount of microcrystalline cellulose used. As a result, the spherical granule preparation with microcrystalline cellulose has good properties in flow rate, packing propertyu and friability and offers a suitable method of granule preparation in pharmaceutical industry.

  • PDF

A Simple Spectrofluorimetric Method for Determination of Mefenamic Acid in Pharmaceutical Preparation and Urine

  • Tabrizi, Ahad Bavili
    • Bulletin of the Korean Chemical Society
    • /
    • v.27 no.8
    • /
    • pp.1199-1202
    • /
    • 2006
  • A simple, sensitive and rapid spectrofluorimetric method was developed for determination of mefenamic acid in pharmaceutical preparation and human urine. The procedure is based on the oxidation of mefenamic acid with cerium (IV) to produce cerium (III), and its fluorescence was monitored at 354 nm after excitation at 255 nm. The variables affecting oxidation of drug were studied and optimized. Under the experimental conditions used, the calibration graphs were linear over the range 0.03-1.5 mg $L^{-1}$. The limit of detection was 0.009 mg $L^{-1}$ and the relative standard deviation for 5 replicate determinations of mefenamic acid at 1.0 mg $L^{-1}$ concentration level was 1.72%. Good recoveries in the range of 102-107 and 102-109% were obtained for pharmaceutical preparation and human urine, respectively. The proposed method was applied to the determination of MF in one pharmaceutical preparation and human urine. The amounts of mefenamic acid found are very similar to those obtained by a standard method.

Enhanced Bioavailability of Itraconazole in Liquid Preparation (난용성 항진균제 이트라코나졸의 액상제제화에 의한 생체이용율 개선)

  • Hwang, Woo-Sin;Kwon, Kwang-Il;Bang, Kyu-Ho
    • YAKHAK HOEJI
    • /
    • v.44 no.6
    • /
    • pp.528-533
    • /
    • 2000
  • This study was to develop an effective itraconazole liquid preparation which exhibits an enhanced bioavailability. The solubility of itraconazole was increased (72-fold) in itraconazole liquid preparation as compared with itraconazole powder. The dissolution rate of itraconazole was higher for itraconazole liquid preparation filled into a hard gelatin capsule with 90% release within 20 min as compared to 55% for $Sporanox^{\circledR}$capsules. The oral absorption of itraconazole liquid preparation and $Sporanox^{\circledR}$tablets were studied in the rat. The area under the concentration-time curve $(AUC_{0-24hr})$ of itraconazole liquid preparation ($90.25\;{\pm}\;8.36\;{\mu}g{\cdot}hr/ml$) increased by 6.2 times compared to that of Sporanox tablets ($14.58\;{\pm}\;1.26\;{\mu}g{\cdot}hr/ml$) after oral administration of itraconazole 15 mg/rat each. $C_{max}$ also increased to $6.87\;{\pm}\;1.15\;{\mu}g/ml$ after administration of liquid preparation $1.58\;{\pm}\;0.16\;{\mu}g/ml$ of $Sporanox^{\circledR}$tablets. These results indicate that in vivo bioavailability of itraconazole liquid preparation was significantly enhanced as compared with $Sporanox^{\circledR}$tablets.

  • PDF

A Study on the Laws and Regulations in Respect of Preparation and Processing of Herbal Medicines at Hospitals of Korean Medicine (한방의료기관 조제·포제 관련 법규에 대한 고찰)

  • Eom, Seok-Ki;Kim, Se-Hyun
    • The Journal of Korean Medical History
    • /
    • v.28 no.1
    • /
    • pp.81-92
    • /
    • 2015
  • Objectives : The purpose of this study is to analyze and identify the problems of current laws and regulations regarding preparation and processing of herbal medicines at hospitals of Korean Medicine. Possible solutions are proposed in the end Methods : Based on the status of hospitals of Korean Medicine and characteristics of Korean Medicine and Korean Medicine industry, I analyze the laws and regulations in regards to preparation and processing of herbal medicines and propose possible solutions. Results : Regulations for the agents, places, and cautions in respect of preparation and processing of herbal medicines are inadequate. Meanwhile, the definition of drug preparation in the Pharmaceutical Affairs Act does not apply to processing and preparation of herbal Medicines at hospitals of Korean Medicine, since herbal medicines accompanies chemical and physical change. Discussions & Conclusions : New regulations for on-site preparation at hospitals of Korean Medicine are necessary. Also, the definition for herbal medicines preparation, which states possible chemical and physical changes of herbal medicines, should be specified in Pharmaceutical Affairs Act.

Determination of DL-Carnitine Hydrochloride in Pharmaceutical Preparation by HPLC using UV Absorption Derivatives (자외부 흡광 유도체를 이용한 염산 DL-카르니틴의 분석)

  • Park, Jun-Kyu;Shin, Hee-Jong;Kim, Jung-Woo
    • Journal of Pharmaceutical Investigation
    • /
    • v.26 no.2
    • /
    • pp.83-89
    • /
    • 1996
  • A reverse-phase HPLC method to determine DL-Carnitine Hydrochloride in pharmaceutical preparation is described. UV absorption derivatives of DL-Carnitine Hydrochloride were formed with p-Bromophenacyl Bromide in an essentially quantitative manner using crown ether as catalyst. The DL-Carnitine-bromophenacyl ester absorbed UV radiation strongly at 254nm, allowing the detection of as small a quantity as 12.5ng of DL-Carnitine Hydrochloride. A linear defection range was $5\;{\times}\;10-8 \;{\sim}\;5\;{\times}\;10-7M$ of DL-Carnitine Hydrochloride. And the linear regression at various drug concentration was =0.999 (n=10). The DL-Carnitine Hydrochloride in pharmaceutical preparation was successfully derivatized and separated from other constituents by reverse phase HPLC with detection at 254 nm.

  • PDF

Preparation and Dissolution Characteristics of Sustained Release Pellets Containing Isosorbide Dinitrate (질산 이소소르비드가 함유된 서방형 펠렛의 제조 및 용출 특성)

  • Lee, Gye-Won;Kim, Hak-Hyung;Ryu, Sung-Kyun
    • Journal of Pharmaceutical Investigation
    • /
    • v.38 no.6
    • /
    • pp.381-385
    • /
    • 2008
  • Isosorbide dinitrate is an oral assiatant therapy agent of angina pectoris, myocardial infarction and congestive heart failure. The objective of this study was to formulate sustained release containing isosorbide dinitrate and assess their formulation variables. Pellets were prepared by fluid bed process and consist of drug layer and membrane layer. The pellets were coated with ethylcellulose along with $5{\sim}15%$ of plasticizer such as triacetin and diethyl butylrate. In vitro evaluation study was performed by comparative dissolution test between test and reference isosorbide dinitrate preparation. We could prepare sustained pellets of isosorbide dinitrate by fluid bed process which were reduced process time and had high content. The pellet coated with 1% ethylcellulose and triacetin(l5%) had a similar dissolution behavior compare to reference isosorbide dinitrate preparation controlling initial dissolution and those of dissolution at 30 min were 17.25 and 17.09%, respectively. Difference factor and similarity factor were $0{\sim}15$ and $50{\sim}100$ and there was no significant difference in bioequivalence between formulations. It might be concluded that our sustained release pellet of isosorbide dinitrate could be an alternatively delivery system to reference drug preparation.

유산균제제(乳酸菌製劑)의 제조공정(製造工程)에 따른 안정성(安定性)

  • Hwang, Jeong-Seop
    • Journal of Pharmaceutical Investigation
    • /
    • v.3 no.3
    • /
    • pp.51-58
    • /
    • 1973
  • It is well known that lactobacillus products are a living bacterial preparation, which acts as the antibacterial and antidiarrhea agents. Beause of the specificity as the living bacterial preparation, this preparation should be remarkably considered to the stabilities in its manufacturing process and storage more than any others. In this report, it has been considered about its stabilities as the following items. 1) Selection of strains. 2) Control of seed strains. 3) Cultivation and its conditions. 4) Dry of microorganisms. 5) Manufacture of products. 6) Products storage. 7) Concerning to administration.

  • PDF

Stability of Minoxidil in Aqueous Solution (수용액중 미녹시딜의 안정성)

  • 김길수
    • YAKHAK HOEJI
    • /
    • v.30 no.5
    • /
    • pp.228-231
    • /
    • 1986
  • The effect of temperature and pH on the degrdation of minoxidil in the aqueous solution was investigated and the stability of pharmaceutical preparation for solution was also studied. The degradation of minoxidil in the aqueous solution was first order type reaction and the rate constant at $20^{\circ}C$ in pH 7.0 phosphate buffer solution was 9.464${\times]10^{-3} day^{-1}$ and calculated activation energy was 11.7 kcal/mol. The degradation of minoxidil was acid-base catalytic reaction and the most stable range of pH was about 5.0. The liquid pharmaceutical preparation was very stable in 3 months.

  • PDF

Studies on Dissolution of Lorazepam Preparation (Lorazepam 제제(製劑)의 용출(溶出)에 관한 연구(硏究))

  • Yang, Jae-Heon
    • Journal of Pharmaceutical Investigation
    • /
    • v.14 no.4
    • /
    • pp.161-169
    • /
    • 1984
  • The tests of dissolution and bioavailability of six formulas of lorazepam tablet under various binders were performed. Lorazepam can be seperated in pharmaceutical preparation and biological plasma by high performance liquid chromatograph. Dissolution process of lorazepam tablet was largely influenced by binder and the dissolution rate was increased by sodium starch glycolate and microcrystalline cellulose, the slower dissolution rate in starch. Bioavailability of lorazepam tablet got relationship with dissolution rate, because tablets containing sodium starch glycolate and microcrystalline cellulose as binder maintained higher plasma level than other binders.

  • PDF